function from the phased array system toolbox Search Results


zero phase digital filter matlab's function filtfilt.m  (MathWorks Inc)
90
MathWorks Inc zero phase digital filter matlab's function filtfilt.m
Zero Phase Digital Filter Matlab's Function Filtfilt.M, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zero phase digital filter matlab's function filtfilt.m/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
zero phase digital filter matlab's function filtfilt.m - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
fir1 in the eegfilt function  (MathWorks Inc)
90
MathWorks Inc fir1 in the eegfilt function
Fir1 In The Eegfilt Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fir1 in the eegfilt function/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
fir1 in the eegfilt function - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
svm algorithm  (MathWorks Inc)
90
MathWorks Inc svm algorithm
Svm Algorithm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/svm algorithm/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
svm algorithm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
belatacept  (Florman Family Foundation)
90
Florman Family Foundation belatacept
Summary of findings for the main comparison
Belatacept, supplied by Florman Family Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/belatacept/product/Florman Family Foundation
Average 90 stars, based on 1 article reviews
belatacept - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
exponential one-phase decay function  (GraphPad Software Inc)
90
GraphPad Software Inc exponential one-phase decay function
Summary of findings for the main comparison
Exponential One Phase Decay Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exponential one-phase decay function/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
exponential one-phase decay function - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
pcm sp50  (Rubitherm Technologies GmbH)
90
Rubitherm Technologies GmbH pcm sp50
Summary of findings for the main comparison
Pcm Sp50, supplied by Rubitherm Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcm sp50/product/Rubitherm Technologies GmbH
Average 90 stars, based on 1 article reviews
pcm sp50 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
4d flow phase-contrast magnetic resonance imaging magnetom skyra  (Siemens AG)
90
Siemens AG 4d flow phase-contrast magnetic resonance imaging magnetom skyra
Summary of findings for the main comparison
4d Flow Phase Contrast Magnetic Resonance Imaging Magnetom Skyra, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4d flow phase-contrast magnetic resonance imaging magnetom skyra/product/Siemens AG
Average 90 stars, based on 1 article reviews
4d flow phase-contrast magnetic resonance imaging magnetom skyra - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
phase map 1  (MathWorks Inc)
90
MathWorks Inc phase map 1
Summary of findings for the main comparison
Phase Map 1, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phase map 1/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
phase map 1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
function generator afg3051c  (Tektronix inc)
90
Tektronix inc function generator afg3051c
Summary of findings for the main comparison
Function Generator Afg3051c, supplied by Tektronix inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/function generator afg3051c/product/Tektronix inc
Average 90 stars, based on 1 article reviews
function generator afg3051c - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
matlab signal processing toolbox  (MathWorks Inc)
98
MathWorks Inc matlab signal processing toolbox
Summary of findings for the main comparison
Matlab Signal Processing Toolbox, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matlab signal processing toolbox/product/MathWorks Inc
Average 98 stars, based on 1 article reviews
matlab signal processing toolbox - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier
nonlinear function one phase decay from graphpad prism 7.0  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear function one phase decay from graphpad prism 7.0
Summary of findings for the main comparison
Nonlinear Function One Phase Decay From Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear function one phase decay from graphpad prism 7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear function one phase decay from graphpad prism 7.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
zero-phase filter filtfilt function  (MathWorks Inc)
90
MathWorks Inc zero-phase filter filtfilt function
Summary of findings for the main comparison
Zero Phase Filter Filtfilt Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zero-phase filter filtfilt function/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
zero-phase filter filtfilt function - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Summary of findings for the main comparison

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Summary of findings for the main comparison

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison, Virus, Control

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 1 Recipient and kidney survival.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 1 Recipient and kidney survival.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 2 Surviving with a functioning transplant.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 2 Surviving with a functioning transplant.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 3 Acute rejection and chronic kidney scarring.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 3 Acute rejection and chronic kidney scarring.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 4 Kidney function, blood pressure and lipids.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 4 Kidney function, blood pressure and lipids.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 5 Malignancy.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 5 Malignancy.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 6 Infections.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 6 Infections.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 7 Diabetes and use of blood pressure medicines.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 1 Any dosage belatacept versus calcineurin inhibitor (CNI), Outcome 7 Diabetes and use of blood pressure medicines.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 1 Recipient and kidney survival.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 1 Recipient and kidney survival.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 2 Surviving with a functioning transplant.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 2 Surviving with a functioning transplant.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 3 Acute rejection and chronic kidney scarring.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 3 Acute rejection and chronic kidney scarring.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 4 Kidney function, blood pressure and lipids.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 4 Kidney function, blood pressure and lipids.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 5 Malignancy.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 5 Malignancy.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 6 Infections.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 6 Infections.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Comparison 2 High versus low dosage belatacept, Outcome 7 Diabetes and use of blood pressure medicines.

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Comparison 2 High versus low dosage belatacept, Outcome 7 Diabetes and use of blood pressure medicines.

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Comparison

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet:

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Transplantation Assay, Clinical Proteomics

Any dosage belatacept versus calcineurin inhibitor (CNI)

Journal: The Cochrane Database of Systematic Reviews

Article Title: Belatacept for kidney transplant recipients

doi: 10.1002/14651858.CD010699.pub2

Figure Lengend Snippet: Any dosage belatacept versus calcineurin inhibitor (CNI)

Article Snippet: [ Google Scholar ] Florman S, Durrbach A, Larsen C, Medina‐Pestana J, Vanrenterghem Y, Vincenti F, et al. Outcomes as a function of donor criteria from a phase iii study of belatacept vs cyclosporine in kidney transplantation (BENEFIT‐EXT) [abstract no: 1773] .

Techniques: Infection